Rare Diseases policy
This essay highlights the main aspects of the of the European Commission’s proposal on Clinical Trials (COM 2012 369) and its relevance for rare diseases…
Please find below some recent news of relevance for the life sciences sector as well as press releases and publications published by us.
We regularly publish interesting news on legal life sciences matters and beyond, such as seminars, publications and other news from our law firm, via our LinkedIn account NOVACOS Law.
Follow us on LinkedIn and receive regular updates
You will also find selected news items below:
This essay highlights the main aspects of the of the European Commission’s proposal on Clinical Trials (COM 2012 369) and its relevance for rare diseases…
Discussion of the ruling of the Higher Regional Court of Karlsruhe (OLG Karlsruhe, 08.03.2012 – 13 W 13/12) regarding the rejection of an expert for prejudice purposes…
This article outlines the main structures of the French Pricing & Reimbursement system for innovative pharmaceuticals…
This essay focuses on how to establish value for orphan drugs in Health Technology Assessments…
The article discusses the question whether service providers in the medical aids sector are allowed to adhere to contracts according to Sec. 127 German Social Code V only partly (e.g. for specific regions, specific products)…
Discussion of a judgement (Saarländisches OLG, 03.08.2011 – 1 U 316/10) regarding the application of the Product Liability Act on medical devices…